## Abstract The use of recombinant human bone morphogenetic protein‐2 (rhBMP‐2) to induce ectopic bone formation requires a carrier. Type I atelocollagen, a biomaterial with a porous structure, excellent operational features, and biocompatibility, is an effective carrier for rhBMP‐2. However, the c
Immobilized recombinant human bone morphogenetic protein-2 enhances the phosphorylation of receptor-activated Smads
✍ Scribed by Eiki Yamachika; Hidetsugu Tsujigiwa; Nobuaki Shirasu; Takaaki Ueno; Yoshirou Sakata; Joji Fukunaga; Nobuyoshi Mizukawa; Masao Yamada; Toshio Sugahara
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 404 KB
- Volume
- 88A
- Category
- Article
- ISSN
- 1549-3296
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Bone morphogenetic protein (BMP)‐2 plays an important role in bone growth and regeneration; however, BMP‐2 is easily lost by diffusion through body fluid and has some inhibitory pathways. To address this problem, we previously immobilized recombinant human BMP‐2 (rhBMP‐2) on succinylated type I atelocollagen. Here, we examined the effect of immobilized rhBMP‐2 in vitro and vivo. In ST2, MC3T3‐E1, and C2C12 cells, alkaline phosphatase activity, which is a marker of osteoblast differentiation, was enhanced more by immobilized than nonimmobilized rhBMP‐2. In addition, the phosphorylation of receptor‐activated Smads, part of the signaling pathway activated by BMP‐2, was prolonged by immobilized rhBMP‐2 in these cells. Furthermore, implantation of immobilized rhBMP‐2 into the backs of rats promoted the formation of mature bone‐like structure. These results demonstrate that immobilized rhBMP‐2 has higher bioactivity than nonimmobilized rhBMP‐2, and, therefore, immobilization of rhBMP‐2 can prolong BMP signaling. © 2008 Wiley Periodicals, Inc. J Biomed Mater Res, 2009
📜 SIMILAR VOLUMES
## Abstract Bone morphogenetic proteins (BMP) stimulate osteoblast differentiation by signal transduction via three BMP receptors (BMPR‐IA, ‐IB, and ‐II). Several growth factors, including transforming growth factor‐β1 (TGF‐β1), fibroblast growth factor‐2 (FGF‐2) and platelet‐derived growth factor‐
To determine if recombinant human bone morphogenetic protein-2 (rhBMP-2) can be adsorbed onto porous ceramic hydroxyapatite (HA) and promote the integration of HA to host bone, 54 subperiosteal pockets were created on the skulls of 19 adult Pasteurella-free white rabbits. Fourteen HA implants were s
## Abstract The objective of this study was to investigate the efficacy of an injectable calcium phosphate cement/silk fibroin/human recombinant bone morphogenetic protein‐2 composite (CPC/SF/rhBMP‐2) in an ovine interbody fusion model. Twenty‐four mature sheep underwent anterior lumbar interbody f
## Abstract Recombinant human bone morphogenetic protein 2 (rhBMP‐2) has been widely employed for the induction of bone growth in animal models and in clinical trials. Since rhBMP‐2 is commercially available only to a very limited extent, we have prepared our own recombinant material for the curren